KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Edwards Lifesciences (EW) Return on Sales (2016 - 2025)

Edwards Lifesciences has reported Return on Sales over the past 17 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Sales at 0.02% for Q4 2025, down 1.0% from a year ago — trailing twelve months through Dec 2025 was 0.0% (down 51.0% YoY), and the annual figure for FY2025 was 0.0%, down 51.0%.
  • Return on Sales for Q4 2025 was 0.02% at Edwards Lifesciences, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for EW hit a ceiling of 2.0% in Q3 2024 and a floor of 0.01% in Q1 2025.
  • Median Return on Sales over the past 5 years was 0.04% (2023), compared with a mean of 0.23%.
  • Biggest five-year swings in Return on Sales: skyrocketed 196bps in 2024 and later tumbled -200bps in 2025.
  • Edwards Lifesciences' Return on Sales stood at 0.25% in 2021, then surged by 85bps to 0.47% in 2022, then crashed by -94bps to 0.03% in 2023, then decreased by -2bps to 0.03% in 2024, then crashed by -39bps to 0.02% in 2025.
  • The last three reported values for Return on Sales were 0.02% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.